Quest Diagnostics (DGX) Income from Continuing Operations (2009 - 2026)
Quest Diagnostics' (DGX) quarterly Income from Continuing Operations came in at 260000000.0 in Q1 2026, up 19.82% year-on-year from 217000000.0 in Q1 2025, and up 4.42% quarter-over-quarter from 249000000.0 in Q4 2025.
Quest Diagnostics (DGX) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Quest Diagnostics has disclosed Income from Continuing Operations across 18 years of filings, most recently posting 260000000.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 260000000.0, up 19.82% year-over-year; the trailing twelve-month figure through Mar 2026 was 1047000000.0 (up 13.93% YoY), and the FY2025 annual result was 1004000000.0, up 11.31% from the prior year.
- Income from Continuing Operations came in at 260000000.0 for Q1 2026 at Quest Diagnostics, up from 249000000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 342000000.0 in Q1 2022 to a low of 113000000.0 in Q4 2022.
- The 5-year median for Income from Continuing Operations is 240000000.0 (2024), against an average of 236411764.71.
- Across the five-year window, Income from Continuing Operations slumped 70.88% in 2022 and soared 74.34% in 2023, its largest moves.
- Quest Diagnostics' Income from Continuing Operations stood at 113000000.0 in 2022, then jumped by 74.34% to 197000000.0 in 2023, then gained by 17.26% to 231000000.0 in 2024, then rose by 7.79% to 249000000.0 in 2025, then grew by 4.42% to 260000000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 260000000.0 (Q1 2026), 249000000.0 (Q4 2025), and 251000000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 269.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | 260.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 260.00 Mn |
| Dec 31, 2025 | 249.00 Mn |
| Sep 30, 2025 | 251.00 Mn |
| Jun 30, 2025 | 287.00 Mn |
| Mar 31, 2025 | 217.00 Mn |
| Dec 31, 2024 | 231.00 Mn |
| Sep 30, 2024 | 231.00 Mn |
| Jun 30, 2024 | 240.00 Mn |
| Mar 31, 2024 | 200.00 Mn |
| Dec 31, 2023 | 197.00 Mn |
| Sep 30, 2023 | 231.00 Mn |
| Jun 30, 2023 | 242.00 Mn |
| Mar 31, 2023 | 212.00 Mn |
| Dec 31, 2022 | 113.00 Mn |
| Sep 30, 2022 | 270.00 Mn |
| Jun 30, 2022 | 246.00 Mn |
| Mar 31, 2022 | 342.00 Mn |
| Dec 31, 2021 | 388.00 Mn |
| Sep 30, 2021 | 501.00 Mn |
| Jun 30, 2021 | 762.00 Mn |